# DESCRIPTION

## BACKGROUND OF THE INVENTION

- introduce field of invention
- describe limitations of current treatments

## SUMMARY OF THE INVENTION

- introduce GPNA oligonucleotides

## DESCRIPTION OF THE PREFERRED EMBODIMENT(S)

- describe GPNA backbone
- explain PTD positioning
- describe PNA/PTD/oligonucleotide properties
- introduce EGFRAS GPNA oligonucleotides
- describe GPNA synthesis
- describe GPNA uptake
- describe GPNA binding

### GRCARTCRGCRTGRCTRCCRCCRG (SEQ ID NO:6);

- introduce alternative sequences

### CRCTRCCRGTRGGRTCRATRGCRTCRC (SEQ ID NO:8),

- introduce additional alternative sequences

### CRGGRAGRGGRTCRGCRATRCGRCTRG (SEQ ID NO:10).

- introduce additional alternative sequences

## Example 1

- describe in vivo antitumor efficacy study

## Example 2

- describe systemic delivery of EGFRAS GPNA study

